Diabetes & Vascular Disease Research

该期刊要求在提交过程中列出每位作者的贡献，并在提交稿件的致谢部分之后包含“作者贡献”标题；提交时提供的信息将在校对阶段显示在该标题下。 模型中文摘要

You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.

该期刊鼓励作者在符合伦理和法律要求的前提下，将研究数据共享到相关公共数据仓库，在数据可用性声明中链接数据，若无法共享则说明原因，并在研究中引用该数据。 模型中文摘要

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…

该期刊要求在指定标题下提供伦理批准声明，即使方法部分已包含相关信息；若无需伦理批准须明确说明。报告涉及人类参与者、人类数据或人类组织的研究时，必须声明相关伦理委员会或机构审查委员会批准或豁免批准，并提供委员会全名、所属机构及批准编号。 模型中文摘要

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…

该期刊为开放获取同行评审期刊，接受的文章在发表后立即免费在线提供，采用知识共享许可并永久在线托管；同行评审接受后须支付一次性文章处理费（APC）2400美元，由资助者、机构或作者支付，提交稿件本身不收费。 模型中文摘要

Diabetes & Vascular Disease Research is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the cost of publishing, …

该期刊采用单盲同行评审，审稿人姓名对作者保密；稿件先经初步评估，不符合指南要求的稿件将被退回修改，超出范围或不合适的稿件可能未经同行评审即被拒稿，通过初评后进入同行评审。 模型中文摘要

The following summary describes the peer review process for this journal: Identity transparency: Single Anonymized Reviewer interacts with: Section Editor and Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscript…

该期刊和Sage严肃对待版权侵权、抄袭及其他违反出版最佳实践的行为，并可能据此采取相应措施。 模型中文摘要

The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.

该期刊考虑已在预印本服务器发布的稿件，提交时须在指定字段填写预印本DOI，并建议在提交时告知编辑部；同行评审期间不应在预印本服务器发布更新版本。 模型中文摘要

The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…

该期刊遵循ICMJE要求，临床试验须在首次招募参与者之前或当时在WHO认可的公共试验注册机构注册，作为考虑发表的条件；试验注册机构名称、URL和注册号必须包含在摘要末尾。 模型中文摘要

The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.